SG11202000269PA - Method for incubating liquids and inactivating viruses - Google Patents
Method for incubating liquids and inactivating virusesInfo
- Publication number
- SG11202000269PA SG11202000269PA SG11202000269PA SG11202000269PA SG11202000269PA SG 11202000269P A SG11202000269P A SG 11202000269PA SG 11202000269P A SG11202000269P A SG 11202000269PA SG 11202000269P A SG11202000269P A SG 11202000269PA SG 11202000269P A SG11202000269P A SG 11202000269PA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- vienna
- incubating
- pct
- liquids
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502761—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip specially adapted for handling suspended solids or molecules independently from the bulk fluid flow, e.g. for trapping or sorting beads, for physically stretching molecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F25/00—Flow mixers; Mixers for falling materials, e.g. solid particles
- B01F25/40—Static mixers
- B01F25/45—Mixers in which the materials to be mixed are pressed together through orifices or interstitial spaces, e.g. between beads
- B01F25/452—Mixers in which the materials to be mixed are pressed together through orifices or interstitial spaces, e.g. between beads characterised by elements provided with orifices or interstitial spaces
- B01F25/4524—Mixers in which the materials to be mixed are pressed together through orifices or interstitial spaces, e.g. between beads characterised by elements provided with orifices or interstitial spaces the components being pressed through foam-like inserts or through a bed of loose bodies, e.g. balls
- B01F25/45241—Mixers in which the materials to be mixed are pressed together through orifices or interstitial spaces, e.g. between beads characterised by elements provided with orifices or interstitial spaces the components being pressed through foam-like inserts or through a bed of loose bodies, e.g. balls through a bed of balls
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F33/00—Other mixers; Mixing plants; Combinations of mixers
- B01F33/30—Micromixers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502769—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by multiphase flow arrangements
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/02—Recovery or purification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/04—Inactivation or attenuation; Producing viral sub-units
- C12N7/06—Inactivation or attenuation by chemical treatment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/00061—Methods of inactivation or attenuation
- C12N2760/00063—Methods of inactivation or attenuation by chemical treatment
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dispersion Chemistry (AREA)
- Clinical Laboratory Science (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Fluid Mechanics (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP17180477 | 2017-07-10 | ||
EP18154196 | 2018-01-30 | ||
PCT/EP2018/068628 WO2019011900A1 (en) | 2017-07-10 | 2018-07-10 | METHOD FOR LIQUID INCUBATION AND VIRUS INACTIVATION |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202000269PA true SG11202000269PA (en) | 2020-02-27 |
Family
ID=63209374
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202000269PA SG11202000269PA (en) | 2017-07-10 | 2018-07-10 | Method for incubating liquids and inactivating viruses |
Country Status (11)
Country | Link |
---|---|
US (1) | US20190022654A1 (zh) |
EP (1) | EP3651811A1 (zh) |
JP (1) | JP7218344B2 (zh) |
KR (1) | KR102623471B1 (zh) |
CN (1) | CN111050809B (zh) |
AU (1) | AU2018299920B2 (zh) |
CA (1) | CA3069593A1 (zh) |
CO (1) | CO2020001426A2 (zh) |
MX (1) | MX2020000353A (zh) |
SG (1) | SG11202000269PA (zh) |
WO (1) | WO2019011900A1 (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3072885B1 (fr) * | 2017-10-27 | 2019-11-15 | IFP Energies Nouvelles | Nouveau systeme de distribution par panneaux meridiens pour un procede de separation en lit mobile simule utilisant n-colonnes en serie |
DE102018009597A1 (de) * | 2018-12-07 | 2020-06-10 | Sartorius Stedim Biotech Gmbh | Vorrichtung und Verfahren zur mehrfachen Änderung der Zusammensetzung eines Fluids |
WO2021222735A1 (en) * | 2020-04-30 | 2021-11-04 | Massachusetts Institute Of Technology | Model-based control for column-based continuous viral inactivation of biopharmaceuticals |
US20220146485A1 (en) * | 2020-11-12 | 2022-05-12 | Essen Instruments, Inc. D/B/A Essen Bioscience, Inc. | Viral clearance evaluation for biological medical product preparation processes |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6214221B1 (en) * | 1999-02-22 | 2001-04-10 | Henry B. Kopf | Method and apparatus for purification of biological substances |
AU2001227653A1 (en) * | 2000-03-09 | 2001-09-17 | Transgenomic, Inc. | Method and system for rna analysis by matched ion polynucleotide chromatography |
IL136552A (en) | 2000-06-05 | 2005-05-17 | Omrix Biopharmaceuticals Ltd | Method for the inactivation of viruses by a solvent - detergent combination and by nanofiltration |
CN1725998A (zh) * | 2002-12-12 | 2006-01-25 | 旭化成株式会社 | 病毒除去袋及使用该病毒除去袋除去病毒的方法 |
EP1615959B1 (en) | 2003-04-10 | 2013-06-05 | Evonik Corporation | A method for the production of emulsion-based micro particles |
AU2005229674B2 (en) * | 2004-11-18 | 2010-11-04 | Kedrion Melville Inc. | Low concentration solvent/detergent process of immuneglobulin with pre-treatment |
BR112013013884A2 (pt) * | 2010-12-06 | 2016-09-13 | Pall Corp | métodos de processamento contínuo para produtos biológicos |
KR101854310B1 (ko) * | 2010-12-15 | 2018-05-04 | 박스알타 인코퍼레이티드 | 개선된 용매-세제법을 이용한 바이러스 불활성화 |
US9028678B2 (en) * | 2011-06-28 | 2015-05-12 | Phillips 66 Company | Scrubbing hydrogen sulfide from hydrotreated product |
EP2578286A1 (en) * | 2011-10-04 | 2013-04-10 | Merck Patent GmbH | Method and apparatus for chromatographic purification |
KR102065355B1 (ko) | 2012-05-31 | 2020-01-13 | 에이전시 포 사이언스, 테크놀로지 앤드 리서치 | 단백질 제조물 내의 응집체 양 감소를 위한 혼합 다관능 표면들의 사용 방법 |
EP2682168A1 (en) | 2012-07-02 | 2014-01-08 | Millipore Corporation | Purification of biological molecules |
ES2900425T3 (es) * | 2013-09-25 | 2022-03-16 | Bioverativ Therapeutics Inc | Métodos de inactivación vírica en columna |
EP2918294A1 (de) | 2014-03-11 | 2015-09-16 | Bayer Technology Services GmbH | Vorrichtung und Verfahren zur kontinuierlichen Virusinaktivierung |
EP3131589B1 (en) | 2014-04-15 | 2023-05-17 | Boehringer Ingelheim International GmbH | Method and use for continuously inactivating a virus during manufacture of a biological product |
EP3088006A1 (de) | 2015-04-28 | 2016-11-02 | Bayer Technology Services GmbH | Verfahren zur kontinuierlichen virusinaktivierung in einem mikroreaktor |
EP3141611A3 (en) * | 2016-10-21 | 2017-05-10 | Bayer Healthcare LLC | Validation of continuous viral clearance |
-
2018
- 2018-07-10 EP EP18755404.3A patent/EP3651811A1/en active Pending
- 2018-07-10 CA CA3069593A patent/CA3069593A1/en active Pending
- 2018-07-10 CN CN201880058016.4A patent/CN111050809B/zh active Active
- 2018-07-10 MX MX2020000353A patent/MX2020000353A/es unknown
- 2018-07-10 US US16/031,171 patent/US20190022654A1/en active Pending
- 2018-07-10 SG SG11202000269PA patent/SG11202000269PA/en unknown
- 2018-07-10 JP JP2020501321A patent/JP7218344B2/ja active Active
- 2018-07-10 WO PCT/EP2018/068628 patent/WO2019011900A1/en unknown
- 2018-07-10 KR KR1020207003391A patent/KR102623471B1/ko active IP Right Grant
- 2018-07-10 AU AU2018299920A patent/AU2018299920B2/en active Active
-
2020
- 2020-02-10 CO CONC2020/0001426A patent/CO2020001426A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
CA3069593A1 (en) | 2019-01-17 |
EP3651811A1 (en) | 2020-05-20 |
KR102623471B1 (ko) | 2024-01-09 |
WO2019011900A1 (en) | 2019-01-17 |
MX2020000353A (es) | 2020-08-17 |
RU2020105866A3 (zh) | 2022-02-25 |
CN111050809A (zh) | 2020-04-21 |
JP7218344B2 (ja) | 2023-02-06 |
AU2018299920A1 (en) | 2020-02-06 |
US20190022654A1 (en) | 2019-01-24 |
AU2018299920B2 (en) | 2024-04-11 |
CN111050809B (zh) | 2021-12-24 |
JP2020526210A (ja) | 2020-08-31 |
CO2020001426A2 (es) | 2020-02-28 |
RU2020105866A (ru) | 2021-08-10 |
KR20200026955A (ko) | 2020-03-11 |
BR112020000524A2 (pt) | 2020-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11202000269PA (en) | Method for incubating liquids and inactivating viruses | |
SG11201807573VA (en) | Methods for providing single-stranded rna | |
SG11201909011PA (en) | Niraparib compositions | |
SG11201906200WA (en) | Nucleic acid-polypeptide compositions and methods of inducing exon skipping | |
SG11201808990QA (en) | Compositions for topical application of compounds | |
SG11201807912SA (en) | Vaccine against rsv | |
SG11201804170RA (en) | Polycyclic tlr7/8 antagonists and use thereof in the treatment of immune disorders | |
SG11201908478SA (en) | Sterilisation method | |
SG11201407898WA (en) | Electrode testing apparatus | |
SG11201807025SA (en) | Crispr/cas systems for c-1 fixing bacteria | |
SG11201809908TA (en) | Stabilized glycopeptide antibiotic formulations | |
SG11201408261UA (en) | Syringe | |
SG11202000145XA (en) | Methods and systems for conditionally regulating gene expression | |
SG11201408614SA (en) | Flexible assembly machine, system and method | |
SG11201903167QA (en) | Compounds and methods for reducing atxn3 expression | |
SG11201908326YA (en) | Methods of treating neurodegenerative diseases | |
SG11201804890TA (en) | Bipyrazolyl derivatives useful for the treatment of autoimmune diseases | |
SG11201806267QA (en) | Organic reactions carried out in aqueous solution in the presence of a hydroxyalkyl(alkyl)cellulose or an alkylcellulose | |
SG11201908512YA (en) | Somatostatin modulators and uses thereof | |
SG11201908127WA (en) | Method for producing multispecific antibodies | |
SG11201908325PA (en) | Process for the preparation of glucuronide drug-linkers and intermediates thereof | |
SG11201906717SA (en) | Methods and systems for associating physical and genetic properties of biological particles | |
SG11201907364WA (en) | Anti-tryptase antibodies, compositions thereof, and uses thereof | |
SG11201809830WA (en) | Selective reduction of cysteine-engineered antibodies | |
SG11201407800SA (en) | Selective binding of biological targets to solid phase ureides |